Blueprint Medicines
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $146,366 | $128,184 | $138,157 | $96,116 |
Gross Profit | 138,919 | 126,252 | 126,947 | 88,115 |
EBITDA | -27,115 | -33,374 | -29,475 | -74,013 |
EBIT | -31,116 | -37,237 | -33,092 | -78,823 |
Net Income | -49,956 | -56,276 | -49,994 | 89,136 |
Net Change In Cash | 146,366 | 128,184 | 138,157 | 96,116 |
Free Cash Flow | -30,296 | -13,662 | -50,641 | -102,617 |
Cash | 102,014 | 89,356 | 54,771 | 113,326 |
Basic Shares | 63,119 | 63,381 | 62,854 | 63,802 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $508,824 | $249,380 | $204,036 | $180,080 |
Gross Profit | 488,661 | 236,584 | 186,223 | 162,146 |
EBITDA | -212,044 | -470,356 | -515,415 | -628,299 |
EBIT | -228,335 | -482,021 | -535,514 | -641,084 |
Net Income | -67,089 | -506,984 | -557,517 | -644,085 |
Net Change In Cash | 508,824 | 249,380 | 204,036 | 180,080 |
Cost of Revenue | -90,008 | -473,797 | ||
Free Cash Flow | -197,216 | -452,909 | -511,196 | -559,894 |
Cash | 102,014 | 71,286 | 119,709 | 209,948 |
Basic Shares | 62,857 | 60,558 | 59,642 | 58,518 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.79 |
2024-09-30 | -$0.89 |
2024-06-30 | -$0.80 |
2024-03-31 | $1.40 |
